• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 10 Aug 2025

Strong 2Q:25 Results Highlight Progress Of Turnaround; Cost Discipline, Commercial Execution, And FCF Momentum Support 2026 Estimate Revisions; Raise Price Target to $19 (From $16)


Schweitzer-Mauduit International (SWM:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Daniel Harriman

    • 10 pages


 

MATV delivered 2Q:25 results ahead of our expectations, with consolidated net sales rising 8% sequentially to $525 million and company-wide margins improving on stronger mix, disciplined cost control, and better execution. Filtration & Advanced Materials (FAM) revenue totaled $204 million and margins improved sequentially on operational discipline. Sustainable and Adhesive Solutions (SAS) generated $321 million in revenue, up 1.1% year over year and 5% on an organic basis, with margin expansion versus 1Q:25, driven by volume growth, favorable mix, and improved commercial execution. Net debt declined to $995 million from $1.04 billion in the prior quarter, while the leverage ratio improved to 4.5x. Free cash flow (FCF) of $48.9 million was the second highest since the 2022 merger. Cost savings remain a central focus, with $15-$20 million expected to benefit the P&L this year and total program savings targeted at $35-$40 million by 2026. Taken together, MATV's operational execution, improved financial position, and targeted self-help actions are laying the foundation for stronger long-term earnings power and greater strategic flexibility, in our view. We maintain our full-year 2025 revenue and adjusted EPS forecasts at $2.0 billion and $0.56, respectively, reflecting a cautious posture amid macroeconomic uncertainty and uneven global demand. We raise our free cash flow estimate to $80 million (from $75 million), supported by strong first half execution. We now project 2026 revenue of $2.100 billion (up from $2.075 billion), adjusted EPS of $1.10 (up from $0.95), and free cash flow of $105 million (from $100 million), reflecting improved commercial execution, cost discipline, and volume-driven operating leverage across both segments.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

Strong 2Q:25 Results Highlight Progress Of Turnaround; Cost Discipline, Commercial Execution, And FCF Momentum Support 2026 Estimate Revisions; Raise Price Target to $19 (From $16)


Schweitzer-Mauduit International (SWM:NYSE) | 0 0 0.0%


  • Published: 10 Aug 2025
  • Author: Daniel Harriman
  • Pages: 10
  • Sidoti & Company


MATV delivered 2Q:25 results ahead of our expectations, with consolidated net sales rising 8% sequentially to $525 million and company-wide margins improving on stronger mix, disciplined cost control, and better execution. Filtration & Advanced Materials (FAM) revenue totaled $204 million and margins improved sequentially on operational discipline. Sustainable and Adhesive Solutions (SAS) generated $321 million in revenue, up 1.1% year over year and 5% on an organic basis, with margin expansion versus 1Q:25, driven by volume growth, favorable mix, and improved commercial execution. Net debt declined to $995 million from $1.04 billion in the prior quarter, while the leverage ratio improved to 4.5x. Free cash flow (FCF) of $48.9 million was the second highest since the 2022 merger. Cost savings remain a central focus, with $15-$20 million expected to benefit the P&L this year and total program savings targeted at $35-$40 million by 2026. Taken together, MATV's operational execution, improved financial position, and targeted self-help actions are laying the foundation for stronger long-term earnings power and greater strategic flexibility, in our view. We maintain our full-year 2025 revenue and adjusted EPS forecasts at $2.0 billion and $0.56, respectively, reflecting a cautious posture amid macroeconomic uncertainty and uneven global demand. We raise our free cash flow estimate to $80 million (from $75 million), supported by strong first half execution. We now project 2026 revenue of $2.100 billion (up from $2.075 billion), adjusted EPS of $1.10 (up from $0.95), and free cash flow of $105 million (from $100 million), reflecting improved commercial execution, cost discipline, and volume-driven operating leverage across both segments.

More Content

More Content

MATV's Swift Recovery Gains Momentum Despite Market Uncertainty; Record Margins And Strong Cash Generation Underscore Good Execution, In Our View; Raise Price Target To $21 (From $19)

Companies: Schweitzer-Mauduit International

Sidoti & Company

2Q:F26 Results Reinforce Stability In Tobacco And Momentum In Ingredients; Sales Performance Supports Our FY26 Outlook And Sustained Cash Flow Strength; Maintain $78 Price Target

Companies: Universal

Sidoti & Company

Execution And Cost Discipline Support Steady 3Q:25 Results, In Our View, With FAM Recovery, SAS Momentum, Strong Cash Generation, And Deleveraging; Maintain $19 Price Target

Companies: Schweitzer-Mauduit International

Sidoti & Company

Tobacco Stability And Ingredients Execution Reinforce Cash Flow Visibility; Reliable Dividend And Expanding Platform Underscore Undervalued Shares, In Our View; Maintain $78 Price Target

Companies: Universal

Sidoti & Company

Takeaways From The Sidoti Conference: MATV's Turnaround Is Gaining Momentum, With Cost Savings, Deleveraging, and Portfolio Actions Driving Execution; Maintain $19 Price Target

Companies: Schweitzer-Mauduit International

Sidoti & Company
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In